Annual EBITDA
-$12.99 M
+$4.78 M+26.90%
December 31, 2023
Summary
- As of February 8, 2025, PMN annual EBITDA is -$12.99 million, with the most recent change of +$4.78 million (+26.90%) on December 31, 2023.
- During the last 3 years, PMN annual EBITDA has fallen by -$8.56 million (-193.34%).
- PMN annual EBITDA is now -927.28% below its all-time high of -$1.26 million, reached on March 1, 2006.
Performance
PMN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$9.28 M
+$11.90 M+453.54%
September 30, 2024
Summary
- As of February 8, 2025, PMN quarterly EBITDA is $9.28 million, with the most recent change of +$11.90 million (+453.54%) on September 30, 2024.
- Over the past year, PMN quarterly EBITDA has increased by +$11.56 million (+505.96%).
- PMN quarterly EBITDA is now at all-time high.
Performance
PMN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$391.80 K
+$11.56 M+96.72%
September 30, 2024
Summary
- As of February 8, 2025, PMN TTM EBITDA is -$391.80 thousand, with the most recent change of +$11.56 million (+96.72%) on September 30, 2024.
- Over the past year, PMN TTM EBITDA has increased by +$16.38 million (+97.66%).
- PMN TTM EBITDA is now -211.20% below its all-time high of -$125.90 thousand, reached on June 1, 2005.
Performance
PMN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PMN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.9% | +506.0% | +97.7% |
| 3 y3 years | -193.3% | +255.8% | +96.9% |
| 5 y5 years | -74.1% | +254.4% | +95.7% |
PMN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.3% | +26.9% | at high | +227.7% | at high | +98.1% |
| 5 y | 5-year | -193.3% | +26.9% | at high | +227.7% | at high | +98.1% |
| alltime | all time | -927.3% | +26.9% | at high | +227.7% | -211.2% | +98.1% |
ProMIS Neurosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.28 M(-453.5%) | -$391.80 K(-96.7%) |
| Jun 2024 | - | -$2.62 M(-26.3%) | -$11.95 M(+3.1%) |
| Mar 2024 | - | -$3.56 M(+2.1%) | -$11.59 M(-10.8%) |
| Dec 2023 | -$12.99 M(-26.9%) | -$3.49 M(+52.5%) | -$12.99 M(-22.5%) |
| Sep 2023 | - | -$2.28 M(+1.0%) | -$16.77 M(-18.0%) |
| Jun 2023 | - | -$2.26 M(-54.4%) | -$20.44 M(-1.7%) |
| Mar 2023 | - | -$4.96 M(-31.7%) | -$20.78 M(+17.0%) |
| Dec 2022 | -$17.77 M(+90.5%) | -$7.26 M(+22.0%) | -$17.77 M(+41.0%) |
| Sep 2022 | - | -$5.95 M(+128.3%) | -$12.60 M(+63.6%) |
| Jun 2022 | - | -$2.61 M(+34.1%) | -$7.70 M(+48.8%) |
| Mar 2022 | - | -$1.94 M(-7.2%) | -$5.18 M(-44.0%) |
| Dec 2021 | -$9.33 M(+110.6%) | -$2.10 M(+98.1%) | -$9.24 M(+17.6%) |
| Sep 2021 | - | -$1.06 M(+1225.2%) | -$7.86 M(-1.4%) |
| Jun 2021 | - | -$79.80 K(-98.7%) | -$7.97 M(-12.4%) |
| Mar 2021 | - | -$6.01 M(+740.8%) | -$9.10 M(+110.1%) |
| Dec 2020 | -$4.43 M(-21.7%) | -$714.40 K(-38.8%) | -$4.33 M(-9.5%) |
| Sep 2020 | - | -$1.17 M(-3.3%) | -$4.79 M(-1.4%) |
| Jun 2020 | - | -$1.21 M(-2.8%) | -$4.85 M(-4.1%) |
| Mar 2020 | - | -$1.24 M(+6.1%) | -$5.06 M(-10.4%) |
| Dec 2019 | -$5.66 M(-24.2%) | - | - |
| Dec 2019 | - | -$1.17 M(-5.3%) | -$5.65 M(-16.5%) |
| Sep 2019 | - | -$1.24 M(-12.6%) | -$6.77 M(-13.1%) |
| Jun 2019 | - | -$1.41 M(-22.8%) | -$7.79 M(-3.3%) |
| Mar 2019 | - | -$1.83 M(-20.1%) | -$8.06 M(+8.4%) |
| Dec 2018 | -$7.46 M(+56.2%) | - | - |
| Dec 2018 | - | -$2.29 M(+1.7%) | -$7.43 M(+24.2%) |
| Sep 2018 | - | -$2.25 M(+33.9%) | -$5.98 M(+18.9%) |
| Jun 2018 | - | -$1.68 M(+39.7%) | -$5.03 M(+4.6%) |
| Mar 2018 | - | -$1.20 M(+43.2%) | -$4.81 M(+3.9%) |
| Dec 2017 | -$4.78 M(+87.0%) | -$840.70 K(-35.4%) | -$4.63 M(-0.4%) |
| Sep 2017 | - | -$1.30 M(-10.9%) | -$4.65 M(+16.2%) |
| Jun 2017 | - | -$1.46 M(+42.3%) | -$4.00 M(+29.7%) |
| Mar 2017 | - | -$1.03 M(+19.2%) | -$3.08 M(+20.1%) |
| Dec 2016 | -$2.55 M(+69.6%) | -$861.00 K(+32.0%) | -$2.57 M(+18.2%) |
| Sep 2016 | - | -$652.40 K(+19.6%) | -$2.17 M(+6.1%) |
| Jun 2016 | - | -$545.30 K(+6.9%) | -$2.05 M(+19.4%) |
| Mar 2016 | - | -$510.20 K(+9.8%) | -$1.71 M(+18.0%) |
| Dec 2015 | -$1.51 M | -$464.70 K(-11.8%) | -$1.45 M(+47.0%) |
| Sep 2015 | - | -$526.60 K(+146.8%) | -$989.20 K(-9.1%) |
| Jun 2015 | - | -$213.40 K(-14.4%) | -$1.09 M(-37.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$249.20 K(-60.2%) | -$1.73 M(-31.1%) |
| Dec 2014 | -$1.84 M(-9.2%) | - | - |
| Sep 2014 | - | -$626.20 K(-27.0%) | -$2.51 M(+7.7%) |
| Jun 2014 | - | -$857.70 K(+37.3%) | -$2.33 M(+14.2%) |
| Mar 2014 | -$2.02 M(-5.7%) | -$624.60 K(+53.9%) | -$2.04 M(+6.3%) |
| Dec 2013 | - | -$405.90 K(-9.1%) | -$1.92 M(-4.3%) |
| Sep 2013 | - | -$446.30 K(-21.4%) | -$2.01 M(-5.7%) |
| Jun 2013 | - | -$567.90 K(+12.8%) | -$2.13 M(-0.3%) |
| Mar 2013 | -$2.15 M(-13.7%) | -$503.60 K(+2.2%) | -$2.14 M(-9.5%) |
| Dec 2012 | - | -$492.70 K(-13.1%) | -$2.36 M(-8.1%) |
| Sep 2012 | - | -$567.20 K(-1.3%) | -$2.57 M(+0.8%) |
| Jun 2012 | - | -$574.90 K(-21.2%) | -$2.55 M(+2.5%) |
| Mar 2012 | -$2.49 M(-20.5%) | -$729.30 K(+4.2%) | -$2.49 M(-5.4%) |
| Dec 2011 | - | -$699.80 K(+28.0%) | -$2.63 M(-3.3%) |
| Sep 2011 | - | -$546.80 K(+6.5%) | -$2.72 M(+31.3%) |
| Jun 2011 | - | -$513.30 K(-41.0%) | -$2.07 M(-31.9%) |
| Mar 2011 | -$3.13 M(-32.2%) | -$870.50 K(+10.1%) | -$3.04 M(-11.8%) |
| Dec 2010 | - | -$790.50 K(-872.0%) | -$3.45 M(-7.2%) |
| Sep 2010 | - | $102.40 K(-106.9%) | -$3.72 M(-25.4%) |
| Jun 2010 | - | -$1.48 M(+16.1%) | -$4.99 M(+11.4%) |
| Mar 2010 | -$4.61 M(+18.2%) | -$1.28 M(+20.7%) | -$4.48 M(+8.0%) |
| Dec 2009 | - | -$1.06 M(-9.0%) | -$4.14 M(+7.2%) |
| Sep 2009 | - | -$1.16 M(+19.6%) | -$3.87 M(+3.7%) |
| Jun 2009 | - | -$973.10 K(+2.7%) | -$3.73 M(-13.0%) |
| Mar 2009 | -$3.90 M(-42.8%) | -$947.80 K(+21.3%) | -$4.28 M(-13.4%) |
| Dec 2008 | - | -$781.10 K(-23.8%) | -$4.94 M(-13.5%) |
| Sep 2008 | - | -$1.03 M(-32.9%) | -$5.71 M(-14.3%) |
| Jun 2008 | - | -$1.53 M(-5.0%) | -$6.67 M(-1.8%) |
| Mar 2008 | -$6.82 M(+88.5%) | -$1.61 M(+3.6%) | -$6.79 M(+0.3%) |
| Dec 2007 | - | -$1.55 M(-21.7%) | -$6.77 M(+13.8%) |
| Sep 2007 | - | -$1.98 M(+19.9%) | -$5.95 M(+27.9%) |
| Jun 2007 | - | -$1.65 M(+4.3%) | -$4.65 M(+26.5%) |
| Mar 2007 | -$3.62 M(+186.2%) | -$1.58 M(+116.9%) | -$3.68 M(+41.5%) |
| Dec 2006 | - | -$730.50 K(+6.8%) | -$2.60 M(+14.9%) |
| Sep 2006 | - | -$684.30 K(+0.9%) | -$2.26 M(+25.0%) |
| Jun 2006 | - | -$678.30 K(+34.1%) | -$1.81 M(+43.9%) |
| Mar 2006 | -$1.26 M | -$506.00 K(+28.4%) | -$1.26 M(+67.3%) |
| Dec 2005 | - | -$394.00 K(+70.3%) | -$751.30 K(+110.3%) |
| Sep 2005 | - | -$231.40 K(+83.8%) | -$357.30 K(+183.8%) |
| Jun 2005 | - | -$125.90 K | -$125.90 K |
FAQ
- What is ProMIS Neurosciences annual EBITDA?
- What is the all time high annual EBITDA for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual EBITDA year-on-year change?
- What is ProMIS Neurosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly EBITDA year-on-year change?
- What is ProMIS Neurosciences TTM EBITDA?
- What is the all time high TTM EBITDA for ProMIS Neurosciences?
- What is ProMIS Neurosciences TTM EBITDA year-on-year change?
What is ProMIS Neurosciences annual EBITDA?
The current annual EBITDA of PMN is -$12.99 M
What is the all time high annual EBITDA for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual EBITDA is -$1.26 M
What is ProMIS Neurosciences annual EBITDA year-on-year change?
Over the past year, PMN annual EBITDA has changed by +$4.78 M (+26.90%)
What is ProMIS Neurosciences quarterly EBITDA?
The current quarterly EBITDA of PMN is $9.28 M
What is the all time high quarterly EBITDA for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly EBITDA is $9.28 M
What is ProMIS Neurosciences quarterly EBITDA year-on-year change?
Over the past year, PMN quarterly EBITDA has changed by +$11.56 M (+505.96%)
What is ProMIS Neurosciences TTM EBITDA?
The current TTM EBITDA of PMN is -$391.80 K
What is the all time high TTM EBITDA for ProMIS Neurosciences?
ProMIS Neurosciences all-time high TTM EBITDA is -$125.90 K
What is ProMIS Neurosciences TTM EBITDA year-on-year change?
Over the past year, PMN TTM EBITDA has changed by +$16.38 M (+97.66%)